Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 6/2019

01-06-2019 | Original Article

Comparing fertility preservation resources and policies between NCCN member and non-member institutions

Authors: Meghan Bowman-Curci, Gwendolyn P. Quinn, Joyce Reinecke, Richard R. Reich, Susan T. Vadaparampil, ENRICH Working group

Published in: Supportive Care in Cancer | Issue 6/2019

Login to get access

Abstract

Purpose

The National Comprehensive Cancer Network (NCCN) created guidelines to facilitate implementation of fertility preservation (FP) discussions and referrals for adolescent and young adult patients. We assessed if availability of workplace FP resources and referral policies differed among learners in the Educating Nurses about Reproductive Health in Cancer Healthcare (ENRICH) training program based on NCCN membership.

Methods

Learners completed a baseline application, including demographic information and the availability of FP resources and referral policies. Learners were categorized as either NCCN members or non-members and chi-square tests compared resources between the two groups.

Results

Learners from NCCN institutions reported the highest rates of established FP referral guidelines (p < .01), reproductive endocrinologist and infertility specialist (REI) on staff (p < .01), partnerships with REI, educational materials for staff (p < .05), and patients (p < .01).

Conclusion

FP resources and referral policies were highest among learners from NCCN member institutions, but areas for development with fertility issues still exist and learners from non-member institutions may assist their workplaces in improving rates of discussions and referrals based on their ENRICH training.

Practice implications

The variation of available resources and referral policies between groups suggests more FP education and training; focusing on implementation programs is needed to make steps towards impactful institutional level resources and policies.
Literature
1.
(2011) What Should the Age Range Be for AYA Oncology? J Adolesc Young Adult Oncol 1(1):3–10
2.
3.
SEER (2011) An estimated projection calculated by the surveillance, epidemiology and end results (SEER) program using SEER 18, 2007–2011
4.
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical Oncology (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology Clinical practice guideline update. J Clin Oncol 31:2500–2510CrossRefPubMedPubMedCentral
5.
Wallace WHB, Anderson RA, Irvine DS (2005) Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 4(4):209–218CrossRef
6.
Mersereau JE, Goodman LR, Deal AM, Gorman JR, Whitcomb BW, Su HI (2013) To preserve or not to preserve: how difficult is the decision about fertility preservation? Cancer 119(22):4044–4050CrossRefPubMedPubMedCentral
7.
Quinn GP, Block R, Clayman ML, Kelvin JF, Arvey SR, Lee JH, Reinecke J, Sehovic I, Jacobsen PB, Reed D, Gonzalez L, Vadaparampil ST, Laronga C, Lee C, Pow-Sang J, Eggly S, Franklin A, Shah B, Fulp WJ, Hayes-Lattin B (2014) If you didn’t document it, it didn’t happen: rates of documentation of discussion of fertility risk in adolescent and young adult (AYA) oncology patients’ medical record. J Onc Pract 11(2):137–144CrossRef
8.
Quinn GP, Vadaparamil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, Keefe DL, Albrecht TL (2009) Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 27(35):5952–5957CrossRefPubMed
9.
Anderson RA, Weddell A, Spoudeas HA, Douglas C, Shalet SM, Levitt G, Hamish W, Wallace B (2008) Do doctors discuss fertility issues before they treat young patients with cancer? Hum Reprod 23(10):2246–2251CrossRefPubMed
10.
11.
12.
13.
Lawson AK, Klock SC, Pavone ME, Hirshfeld-Cytron J, Smith KN, Kazer RR (2015) Psychological counseling of female fertility preservation patients. J Psychosoc Oncol 33(4):333–353CrossRefPubMedPubMedCentral
14.
Vadaparampil ST, Quinn G, Clayton HB, King LM, Miree CA (2008) Institutional availability of fertility preservation. Clin Pediatr 24:255–263
15.
Vadaparampil ST, Hutchins NM, Quinn GP (2013) Reproductive health in the adolescent and young adult cancer patient: an innovative training program for oncology nurses. J Cancer Educ 28:197–208CrossRefPubMedPubMedCentral
16.
Vadaparampila, S.T., Gwede C.K., Meade, C.D., Kelvin, J.F., Reich, R.R., Reinecke, J., Bowman, M.L., Sehovic, I., Quinn, G.P., Enrich research group (2016) ENRICH: A promising oncology nurse training program to implement ASCO clinical practice guidelines on fertility for AYA cancer patients. Patient Educ Couns 99(11):1907–1910
17.
18.
Reinecke JD, Kelvin JF, Arvey SR, Quinn GP, Levine J, Beck LN, Miller A (2012) Implementing a systematic approach to meeting patients' cancer and fertility needs: a review of the fertile hope centers of excellence program. J Oncol Pract 8:303–308CrossRefPubMedPubMedCentral
Metadata
Title
Comparing fertility preservation resources and policies between NCCN member and non-member institutions
Authors
Meghan Bowman-Curci
Gwendolyn P. Quinn
Joyce Reinecke
Richard R. Reich
Susan T. Vadaparampil
ENRICH Working group
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4475-8

Other articles of this Issue 6/2019

Supportive Care in Cancer 6/2019 Go to the issue

Original Article

One-minute time interval estimation as a novel ultrashort tool for distress screening

Original Article

Gaps in communication between cancer patients and healthcare providers: symptom distress and patients’ intentions to disclose

Review Article

Establishing effective patient navigation programs in oncology

Original Article

Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis

Original Article

Predictors of sedentary behavior among colorectal survivors

Original Article

Establishing an integrative oncology service in the Australian healthcare setting—the Chris O’Brien Lifehouse Hospital experience
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits